IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

FERRI, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.809
NA - Nord America 9.152
AS - Asia 8.185
SA - Sud America 743
AF - Africa 141
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 10
Totale 29.078
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.846
GB - Regno Unito 4.129
CN - Cina 2.699
SG - Singapore 2.514
IT - Italia 2.130
DE - Germania 1.219
RU - Federazione Russa 748
SE - Svezia 677
HK - Hong Kong 612
BR - Brasile 567
VN - Vietnam 514
IN - India 438
FR - Francia 419
BD - Bangladesh 296
NL - Olanda 287
KR - Corea 269
IE - Irlanda 257
TR - Turchia 250
FI - Finlandia 229
UA - Ucraina 213
CA - Canada 192
JP - Giappone 168
ID - Indonesia 123
DK - Danimarca 97
PL - Polonia 95
EU - Europa 94
ES - Italia 57
AR - Argentina 55
CO - Colombia 52
MX - Messico 42
BE - Belgio 41
GR - Grecia 41
ZA - Sudafrica 37
CI - Costa d'Avorio 36
AU - Australia 34
IL - Israele 33
IQ - Iraq 33
PK - Pakistan 31
CH - Svizzera 29
AT - Austria 25
RO - Romania 24
EC - Ecuador 22
TH - Thailandia 22
PH - Filippine 21
TW - Taiwan 21
UZ - Uzbekistan 18
CL - Cile 17
MY - Malesia 17
CR - Costa Rica 16
EG - Egitto 16
SA - Arabia Saudita 15
PS - Palestinian Territory 12
VE - Venezuela 12
IR - Iran 11
JM - Giamaica 10
PE - Perù 10
CZ - Repubblica Ceca 9
KZ - Kazakistan 9
EE - Estonia 8
NO - Norvegia 8
PT - Portogallo 8
RS - Serbia 8
AZ - Azerbaigian 7
HN - Honduras 7
HU - Ungheria 7
KE - Kenya 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
DO - Repubblica Dominicana 6
GT - Guatemala 6
JO - Giordania 6
MA - Marocco 6
NP - Nepal 6
BG - Bulgaria 5
CM - Camerun 5
DZ - Algeria 5
KG - Kirghizistan 5
LB - Libano 5
LT - Lituania 5
LU - Lussemburgo 5
NI - Nicaragua 5
PR - Porto Rico 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
BY - Bielorussia 4
CU - Cuba 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
PA - Panama 4
SC - Seychelles 4
UY - Uruguay 4
CG - Congo 3
LK - Sri Lanka 3
MU - Mauritius 3
OM - Oman 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
Totale 29.123
Salva come PNG Salva come JPEG
Città #
Southend 3.807
Singapore 1.527
Ashburn 860
Chandler 627
Hong Kong 573
Milan 567
Beijing 480
San Jose 480
Dallas 412
Fairfield 352
Wilmington 348
Seattle 338
Princeton 321
Council Bluffs 313
Frankfurt am Main 306
Hanover 261
Ann Arbor 259
Dublin 259
Houston 212
Santa Clara 209
Woodbridge 205
New York 200
Los Angeles 193
Mountain View 189
Nanjing 165
Dearborn 154
Ho Chi Minh City 154
Guangzhou 144
Lauterbourg 143
Redmond 138
Buffalo 130
Bengaluru 124
Cambridge 124
Des Moines 120
Hanoi 119
Moscow 116
Shanghai 105
Grafing 101
Parma 99
Redwood City 98
Boardman 96
Jacksonville 96
Sunnyvale 96
The Dalles 87
Jinan 83
Tokyo 82
Jakarta 77
Toronto 77
Helsinki 75
Sakarya 69
Seoul 69
Columbus 67
Rome 67
São Paulo 66
Munich 65
Warsaw 65
Shenyang 64
Nanchang 62
Phoenix 60
Tianjin 57
Istanbul 55
Changsha 54
Hefei 53
Serra 52
Berlin 50
Hangzhou 48
Shenzhen 47
Eitensheim 46
Hebei 46
Medford 43
Cangzhou 40
Somerville 40
Bogotá 37
Zhengzhou 37
Abidjan 36
Andover 36
London 34
Brussels 32
Fuzhou 32
Jiaxing 31
Ottawa 30
Padova 30
San Diego 29
Wuhan 29
Atlanta 27
Roxbury 27
Taizhou 25
Turin 25
Orem 24
Chicago 23
Como 23
Naples 23
Athens 22
Bitonto 22
Da Nang 22
Dong Ket 22
Mumbai 22
Bologna 21
Bühl 21
Kiez 21
Totale 18.149
Salva come PNG Salva come JPEG
Nome #
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease 1.067
The small heat shock protein B8 (HSPB8) modulates proliferation and migration of breast cancer cells 500
Identificazione di nuovi inibitori selettivi della proteina Rac1: possibili implicazioni farmacologiche 444
Present therapeutic role of cholesteryl ester transfer protein inhibitors 427
A selective alpha1D-adrenoreceptor antagonist inhibits human prostate cancer cell proliferation and motility "in vitro" 412
PCSK9 induces a pro-inflammatory response in macrophages 390
High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation 386
Analysis of hindgut microbiome of sheep and effect of different husbandry conditions 347
Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in PtII complexes on human carcinoma cell lines: A comparative study with cisplatin 315
Development of poly(lactide-co-glycolide) nanoparticles functionalized with a mitochondria penetrating peptide 309
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 296
Are pleiotropic effects of statins real? 293
Methanethiosulfonate derivatives as ligands of the STAT3-SH2 domain 279
Sex-specific predictors of PCSK9 levels in a European population : the IMPROVE study 271
Integrin-mediated transcriptional activation of inhibitor of apoptosis proteins protects smooth muscle cells against apoptosis induced by degraded collagen 268
Peptide modulators of Rac1/Tiam1 protein-protein interaction: An alternative approach for cardiovascular diseases 268
Monofunctional Pt(II) complexes based on 8-aminoquinoline: synthesis and pharmacological characterization 268
Liver fat accumulation is associated with circulating PCSK9 levels 266
Ajoene, a garlic compound, inhibits protein prenylation and arterial smooth muscle cell proliferation 262
Identificazione di nuovi inibitori selettivi della proteina Rac1: possibili implicazioni farmacologiche 261
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels 255
Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study 248
Fluvastatin synergistically improves the antiproliferative effect of everolimus on rat smooth muscle cells by altering p27Kip1/cyclin E expression 247
Cytotoxic platinum(II) complexes bearing N-heterocycle rings as novel theranostic agents 245
xIAP induces cell-cycle arrest and activates nuclear factor-kappaB : new survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells 242
Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits 239
3-Aryl-N-aminoylsulfonylphenyl-1H-pyrazole-5-carboxamides : a new class of selective Rac inhibitors 239
Relationship between circulating PCSK9 and markers of subclinical atherosclerosis—the improve study 238
Inhibition of smooth muscle cell migration and proliferation by statins 236
NITRIC OXIDE-DONATING STATINS EXERT BENEFICIAL EFFECTS ON ACUTE VASCULAR INFLAMMATION IN NORMOCHOLESTEROLEMIC RABBITS 234
Aliskiren inhibits prorenin-induced human aortic smooth muscle cell migration 232
Fibrillar collagen inhibits cholesterol biosynthesis in human aortic smooth muscle cells 231
Simvastatin reduces MMP1 expression in human smooth muscle cells cultured on polymerized collagen by inhibiting Rac1 activation 229
2-Amino-3-(phenylsulfanyl)norbornane-2-carboxylate : an Appealing Scaffold for the Design of Rac1-Tiam1 Protein-Protein Interaction Inhibitors 229
Dipeptide Nanotubes Containing Unnatural Fluorine-Substituted beta(2,3)-Diarylamino Acid and L-Alanine as Candidates for Biomedical Applications 229
Pro-inflammatory cytokines and adipokines regulate PCSK9 expression in HepG2 cells 229
Identification of the first enantiopure Rac1–Tiam1 protein–protein interaction inhibitor and its optimized synthesis via phosphine free remote group directed hydroarylation 227
17-AAG increases autophagic removal of mutant androgen receptor in spinal and bulbar muscular atrophy 226
Thiazole- and imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase 225
Cationic platinum(II) complexes active in vivo as anticancer drugs 222
In vitro and in vivo studies of antiatherosclerotic properties of everolimus 220
Promising antiproliferative platinum(II) complexes based on imidazole moiety: synthesis, evaluation in HCT-116 cancer cell line and interaction with Ctr-1 Met-rich domain 220
Liver fat accumulation is associated with circulating PCSK9 220
SOCS-3 induces PCSK9 expression in hepatic HepG2 cell line 219
Cleavage of focal adhesion kinase in vascular smooth muscle cells overexpressing membrane-type matrix metalloproteinases 217
PCSK9 Involvement in Aortic Valve Calcification 217
Cigarette smoke and monocytes : a dangerous relationship for the endothelium? 211
A field-based disparity analysis of new 1,2,5-oxadiazole derivatives endowed with antiproliferative activity 211
New rosmaricine derivates as anticancer agents 210
Fibronectin extra domain A stabilises atherosclerotic plaques in apolipoprotein E and in LDL-receptor-deficient mice 210
Vascular myocytes preserve phenotypic features in culture 207
Adipose tissue related adipokines and cytokines regulate PCSK9 expression in HepG2 cells 206
Biomarkers for atherosclerosis: pathophysiological role and pharmacological modulation 204
Muscle cells and motoneurons differentially remove mutant SOD1 causing familial amyotrophic lateral sclerosis 204
STAT3 inhibition induces PCSK9 in hepatic cell line: possible involvement in hypertriglyceridemia associated with insulin resistance 203
Farnesyltransferase inhibitors : CAAX mimetics based on different biaryl scaffolds 202
STAT3 inhibition induces PCSK9 in hepatic cell line: possible involvement in hypertriglyceridemia associated with insulin resistance 202
PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 SECRETED BY CULTURED SMOOTH MUSCLE CELLS REDUCES MACROPHAGES LOW DENSITY LIPOPROTEIN RECEPTOR LEVELS AND FACILITATES SMOOTH MUSCLE CELL MIGRATION 201
Neuronal PCSK9 regulates cognitive performances via the modulation of ApoER2 synaptic localization 199
REL-1017 (Esmethadone) Increases Circulating BDNF Levels in Healthy Subjects of a Phase 1 Clinical Study 199
Effect of S(-) perillic acid on protein prenylation and arterial smooth muscle cell proliferation 196
PCSK9 expression is regulated by pro-inflammatory cytokines and adipokines in HEPG2 cells 195
Peptide-based modulation of helix-loop-helix proteins 194
Isothiazoles. Part XV. A mild and efficient synthesis of new antiproliferative 5-sulfanylsubstituted 3-alkylaminoisothiazole 1,1-dioxides 191
Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis 191
Suppressor of cytokine signaling-3 (SOCS-3) induces proprotein convertase subtilisin kexin type 9 (PCSK9) expression in hepatic hepg2 cell line 191
Antiatherosclerotic activities of mibefradil in cell culture 190
INHIBITION OF RAT SMOOTH MUSCLE CELL PROLIFERATION BY NEW POTENTIAL TOPOISOMERASEs INHIBITORS 189
Proprotein convertase subtilisin kexin type 9 (PCSK9)secreted by cultured smooth muscle cells reduces macrophages LDLR levels 189
PCSK9 deficient mice are protected from neointima formation in carotid artery injury model 189
Upregulation of Lectin-Like Oxidized Low Density Lipoprotein Receptor 1 (Lox-1) Expression in Human Endothelial Cells by Modified High Density Lipoproteins 188
Isothiazole dioxide derivative 6n inhibits vascular smooth muscle cell proliferation and protein farnesylation 186
Human megakaryocytes confer tissue factor to a subset of shed platelets to stimulate thrombin generation 185
Nitric Oxide-Donating Atorvastatin Attenuates Neutrophil Recruitment During Vascular Inflammation Independent of Changes in Plasma Cholesterol 184
Thematic review series : the immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease 182
Controle pharmacologique de la voie de biosynthese du mevalonate: effet sur la proliferation de cellules musculaires lisses arterielles 181
STAT3 direct inhibitors: from MD77 to AC33 180
Proprotein convertase subtilisin kexin type 9 and high-density lipoprotein metabolism : experimental animal models and clinical evidence 179
Disegno, sintesi e valutazione farmacologica di nuovi inibitori della proteina Rac1 178
Fas and Fas-associated death domain protein regulate monocyte chemoattractant protein-1 expression by human smooth muscle cells through caspase- and calpain-dependent release of interleukin-1alpha 177
Expression and secretion of PCSK9 from cultured smooth muscle cells: evidence for a direct role in atherogenesis 177
Synthesis, Structural and Biological Evaluation of Bis-Heteroarylmaleimides and Bis-Heterofused Imides 175
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels 175
Design, synthesis and pharmacological evaluation of new Rac1 protein inhibitors 175
In vitro enhanced antiproliferative activity of everolimus by fluvastatin on arterial smooth muscle cells 174
Muscle cells and motoneurons differentially remove mutant SOD1 in two cell models of amyotrophic lateral sclerosis 174
Direct vascular effects of HMG-CoA reductase inhibitors 174
Synthetic peptides containing a conserved sequence motif of the Id protein family modulate vascular smooth muscle cell phenotype 172
Chemotactic effect of prorenin on human aortic smooth muscle cells : a novel function of the (pro)renin receptor 172
Effect of proprotein convertase subtilisin kexin type 9 (PCSK9) on smooth muscle cell proliferation and migration 171
High density lipoproteins inhibit oxidative stress-induced prostate cancer cell proliferation 171
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels 170
Aliskiren reduces prorenin receptor expression and activity in cultured human aortic smooth muscle cells 167
Lipid-modified proteins as biomarkers for cardiovascular disease: a review 165
Virtual screening approach for the identification of new Rac1 inhibitors 165
New sulfurated cinnamic acid derivatives as multitarget anticancer agents 164
Risk Factors for SAMS 164
ALISKIREN REDUCES PRORENIN RECEPTOR EXPRESSION AND ACTIVITY IN CULTURED HUMAN AORTIC SMOOTH MUSCLE CELLS 160
Pleiotropic effects of statins in atherosclerosis and diabetes 159
A peptidomimetic approach for the modulation of the protein-protein interaction of negative trancription factors 158
Totale 23.330
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.078
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021475 0 0 0 0 0 0 0 0 0 0 346 129
2021/20222.325 233 107 81 136 151 193 194 145 266 220 174 425
2022/20232.378 307 240 228 248 244 457 60 160 254 22 94 64
2023/20241.734 69 149 154 204 354 116 49 101 45 130 160 203
2024/20253.726 145 347 55 377 291 162 160 369 210 369 323 918
2025/20267.893 793 450 970 588 883 608 901 419 912 592 777 0
Totale 30.494